Product Description: SIM-0235 is humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets and inhibits TNFR2, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001)[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]F. Liu, et al. SIM1811-03 (SIM0235), an anti-tumor necrosis factor receptor-2 (TNFR2) monoclonal antibody, in patients with advanced solid tumor and/or cutaneous T cell lymphomas (CTCL): Preliminary results from an on-going first-in-human phase I trial in China. Abstract onlyVolume 34, Supplement 2S485October 2023.
Molecular Weight: N/A
Research Area: Cancer
Target: TNF Receptor